Page 3 - Pharma Stocks

Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks

After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100

Indian shares open flat as pharma boost offsets losses in tech stocks

Indian shares were largely unchanged on Monday, as gains in pharmaceutical stocks and heavyweight Reliance Industries were offset by losses in information technology stocks

Sensex rebounds 359 points; financial, pharma stocks key drivers

The 30-share Sensex finished 358.83 points or 0.69 per cent higher at 52,300.47. Intra-day, the index swung between a high of 52,346.35 and a low of 51,957.92

After 100% gain since Nov, can the rally in Gland Pharma stock continue?

Gland's prospects remain strong, say analysts, as it has a robust pipeline of products with 50 pending Abbreviated New Drug Applications (ANDAs) and a healthy filing rate of 21 ANDAs in 9MFY21

Cipla dips 4% on lower than expected March quarter earnings

The company's performance in Q4FY21 was weighed by moderate YoY growth in India Domestic Formulation (DF)/South Africa and decline in API sales for the quarter

Sensex, Nifty rise for 4th straight session; pharma, banking stocks gain

Over the last four sessions, the Sensex has gained 1,248.90 points or 2.58 per cent.

Laurus Labs shares advance 5% on strong growth outlook

Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model

Everest Kanto, Morepen Lab: 5 stocks to make your portfolio Covid-proof

Major stocks in the healthcare equipment sector are showing firm upside of over 15 per cent

Fast-track Covid-19 vaccine approval gives indices a shot in the arm

Sensex, Nifty rise 1.4%; experts see volatility continuing in near term

The second wave: Pharma stocks make a comeback as Covid-19 cases rise

However, analysts say these stocks may not deliver bumper returns like last year

Orchid Pharma rises from ashes, expects to make profits in 12 months

Dhanuka Pharmaceuticals that took over the company almost a year ago, nursed it back to health from bankruptcy

This pharma stock has zoomed over 10,000% in 96 trading days

Orchid Pharma shares were locked in the upper circuit for the 96th straight trading day

New launches, market share gains to sustain Gland Pharma's sales trajectory

Earnings are expected to grow over 25 per cent over the next two years

Pharma stocks may hold ground as volatility grips global markets

The Nifty Pharma index was down 1.76 per cent on Friday compared to a 568-point or nearly 3.8 per cent slide in the Nifty50 on weak global cues

Investors turn to pharma stocks amid market crash; Nifty Pharma gains 1.5%

Among individual stocks, Lupin zoomed 3.4 per cent in the intra-day trade and hit a high of Rs 1,060, Sun Pharmaceuticals advanced 2 per cent, and Dr Reddy's Labs gained 1.7 per cent.

Weak Q3 show, margin pressures to keep Sanofi stock under pressure

Growth led by power brands and new launches could recover as pandemic impact wanes

Weak Q3, downgrades to keep Bayer CropScience stock under pressure

Given the focus on volume growth and price cuts margin pressures may remain

Apollo Hospitals to step up pharmacy, retail biz, eyes Rs 10,000 cr revenue

Core hospital segment too is looking up on the back of rise in occupancies, footfalls

Why pharma stocks are underperforming despite Rs 2.23 trn Budget allocation

Much of the increase in this year's Budget allocation for health and well-being is attributed to expenditure set aside for Covid-19 vaccination

Alembic Pharma extends decline on mixed December quarter results

Motilal Oswal Securities said Alembic Pharma missed Q3FY21 earnings estimate, weighed by lower-than-expected sales in the US